Google provides translated versions of our Help Centre, though they are not meant to change the content of our policies. The English version is the official language we use to enforce our policies. To view this article in a different language, use the language dropdown at the bottom of the page.
In June 2023, the Google Ads healthcare and medicines policy will be updated to clarify restrictions around prescription animal medications that are not prone to human abuse or other misuse. Currently, advertisers can use a small set of pre-approved prescription animal drug terms in ads that target personalised advertising audience segments, such as remarketing lists. With this update, in line with the personalised advertising policy, advertisers will be able to use prescription animal drug terms where the drugs and listed ingredients are intended for animal use and are not prone to human abuse or other misuse.
This update will retain existing restrictions on prescription animal drug terms under the healthcare and medicines policy:
Restricted animal drug terms
For campaigns targeting Canada or the United States, Google restricts the use of prescription animal drug terms when the drugs are intended for animal use and are not prone to human abuse or other misuse. Animal prescription drugs that are prone to human abuse or other misuse are subject to the restricted drug terms policy. While you do not need to be certified to serve your ads, you must be certified for the keyword targeting of animal prescription drug terms in Canada and the United States – see how to apply.
(Posted June 2023)